Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04434313Not ApplicableCompleted

Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™

Role: lead

NCT03649217Not ApplicableCompleted

Active Limb Orthosis for Home-Use Stroke Hemiparetic Gait Rehabilitation

Role: collaborator

NCT02185404Not ApplicableCompleted

iStride(TM) Device Used for Stroke Rehabilitation

Role: collaborator

All 3 trials loaded